ATE496932T1 - Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 - Google Patents
Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10Info
- Publication number
- ATE496932T1 ATE496932T1 AT02718923T AT02718923T ATE496932T1 AT E496932 T1 ATE496932 T1 AT E496932T1 AT 02718923 T AT02718923 T AT 02718923T AT 02718923 T AT02718923 T AT 02718923T AT E496932 T1 ATE496932 T1 AT E496932T1
- Authority
- AT
- Austria
- Prior art keywords
- ccr5
- antibody
- chemokine receptor
- protein chemokine
- hdgnr10
- Prior art date
Links
- 102000009410 Chemokine receptor Human genes 0.000 title abstract 4
- 108050000299 Chemokine receptor Proteins 0.000 title abstract 4
- 101000887490 Homo sapiens Guanine nucleotide-binding protein G(z) subunit alpha Proteins 0.000 title 1
- 102000052301 human GNAZ Human genes 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 108091006027 G proteins Proteins 0.000 abstract 1
- 102000030782 GTP binding Human genes 0.000 abstract 1
- 108091000058 GTP-Binding Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/004153 WO2001058916A2 (en) | 2000-02-09 | 2001-02-09 | Antibodies to ccr5 |
US09/779,880 US20020061834A1 (en) | 2000-02-09 | 2001-02-09 | Human G-protein Chemokine receptor (CCR5) HDGNR10 |
US29725701P | 2001-06-12 | 2001-06-12 | |
US31045801P | 2001-08-08 | 2001-08-08 | |
US32844701P | 2001-10-12 | 2001-10-12 | |
US34172501P | 2001-12-21 | 2001-12-21 | |
PCT/US2002/003634 WO2002064612A2 (en) | 2001-02-09 | 2002-02-08 | Human g-protein chemokine receptor (ccr5) hdgnr10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE496932T1 true ATE496932T1 (de) | 2011-02-15 |
Family
ID=46150070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02718923T ATE496932T1 (de) | 2001-02-09 | 2002-02-08 | Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR20030081437A (de) |
AT (1) | ATE496932T1 (de) |
AU (1) | AU2008209670A1 (de) |
MX (1) | MXPA03007186A (de) |
NZ (1) | NZ527126A (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2857168C (en) * | 2011-12-01 | 2020-10-27 | Protevobio, Inc. | Protein inhibitors to complement and vegf pathways and methods of use thereof |
-
2002
- 2002-02-08 AT AT02718923T patent/ATE496932T1/de active
- 2002-02-08 MX MXPA03007186A patent/MXPA03007186A/es unknown
- 2002-02-08 KR KR10-2003-7010489A patent/KR20030081437A/ko not_active Application Discontinuation
- 2002-02-08 NZ NZ527126A patent/NZ527126A/en unknown
-
2008
- 2008-09-03 AU AU2008209670A patent/AU2008209670A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20030081437A (ko) | 2003-10-17 |
MXPA03007186A (es) | 2005-07-01 |
NZ527126A (en) | 2007-04-27 |
AU2008209670A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scallon et al. | Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions | |
CA2430135A1 (en) | Recombinant anti-cd30 antibodies and uses thereof | |
TWI335336B (de) | ||
CA2213833A1 (en) | Vascular endothelial cell growth factor antagonists | |
KR20210005872A (ko) | 이작용성 단백질 및 이의 작제물 | |
CN117024599A (zh) | 双特异性信号传导剂及其用途 | |
CN110573172A (zh) | 靶向的工程化干扰素及其用途 | |
US20210238264A1 (en) | Therapeutic targeting of non-cellular structures | |
US20090123456A1 (en) | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists | |
TW201023855A (en) | Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan | |
EP1798242A3 (de) | Anti-IGF-IF-Antikörper und ihre Anwendungen | |
JP2005506035A5 (de) | ||
NZ515464A (en) | Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains | |
MXPA05007823A (es) | Composicion y tratamiento de enfermedades desmielizantes y paralisis por administracion de agentes remielinizantes. | |
JP2004518624A5 (de) | ||
JP2018535948A5 (de) | ||
CA3050601A1 (en) | Immune-cell targeted bispecific chimeric proteins and uses thereof | |
KR20090122910A (ko) | 류마티스 관절염의 진단 및 치료에 사용되는 항-cd6 단일클론성 항체를 포함하는 약학 조성물 | |
Döring et al. | Identification and characterization of a TNFα antagonist derived from a monoclonal antibody | |
Li et al. | Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone | |
KR20200040881A (ko) | 항-pacap 항체 | |
Abe et al. | Role of 55-and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. | |
ATE496932T1 (de) | Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 | |
Lochner et al. | Generation of neutralizing mouse anti-mouse IL-18 antibodies for inhibition of inflammatory responses in vivo | |
NZ337601A (en) | Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics by inhibiting IgE expression |